X-150660393-A-G
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 4P and 9B. PM1PM5BP6BS1BS2
The ENST00000370396.7(MTM1):āc.1376A>Gā(p.Asn459Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000184 in 1,194,034 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 5 hemizygotes in GnomAD. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. N459I) has been classified as Pathogenic.
Frequency
Consequence
ENST00000370396.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MTM1 | NM_000252.3 | c.1376A>G | p.Asn459Ser | missense_variant | 13/15 | ENST00000370396.7 | NP_000243.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MTM1 | ENST00000370396.7 | c.1376A>G | p.Asn459Ser | missense_variant | 13/15 | 1 | NM_000252.3 | ENSP00000359423 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000178 AC: 2AN: 112166Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34344
GnomAD3 exomes AF: 0.0000548 AC: 10AN: 182415Hom.: 0 AF XY: 0.0000596 AC XY: 4AN XY: 67081
GnomAD4 exome AF: 0.0000185 AC: 20AN: 1081818Hom.: 0 Cov.: 27 AF XY: 0.0000143 AC XY: 5AN XY: 349724
GnomAD4 genome AF: 0.0000178 AC: 2AN: 112216Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34404
ClinVar
Submissions by phenotype
Severe X-linked myotubular myopathy Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 30, 2023 | - - |
Likely benign, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 16, 2020 | - - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 08, 2022 | The c.1376A>G (p.N459S) alteration is located in exon 13 (coding exon 12) of the MTM1 gene. This alteration results from a A to G substitution at nucleotide position 1376, causing the asparagine (N) at amino acid position 459 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Jun 26, 2020 | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; In-silico analysis is inconclusive as to whether the variant alters gene splicing. In the absence of RNA/functional studies, the actual effect of this sequence change is unknown. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at